Open
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
Grant from National Institutes of Health
- Funder
- National Institutes of Health
- Deadline
- October 15, 2027
- Status
- Open
- Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving…
- Official source
- grants.gov
Open in GrantAuthority. The full listing, application link, requirements, attachments, program contacts and your organization's fit score are available with a free account.